Key facts
- Kurage’s last known valuation is $8.7M (Dec 2024).
- It has raised $3.5M; the latest was Seed Round ($3.3M) in Dec 2024.
- Notable investors include BWOOD Equity, Femmes Business Angels, Good Only Ventures, Pulsalys, WeLikeStartup — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Kurage
- ·The full record, as it builds
Funding rounds
No funding rounds for Kurage are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kurage
Developer of scientific research and development software designed to restore mobility to those who have lost it. The company's platform leverages a combination of artificial intelligence and functional electrical stimulation (FES) to diagnose, control, and monitor the central nervous system, enabling rehabilitation of neuro-injured individuals through physical activity when the brain's motor functions are impaired.
- Sector
- Healthcare
- HQ
- Lyon, France
- Founded
- 2020
- Employees
- 30
- Website
- kurage.fr/
- Ownership
- Privately Held (backing)
Kurage doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kurage shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kurage in its N-PORT filings yet. We sweep new filings monthly.